Indaptus Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Indaptus Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors (NCT05651022) | Indaptus Therapeutics, Inc | 2023-02-28 |
Track Indaptus Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.